Management of Polycystic Ovary Syndrome in Patients Not Seeking Pregnancy
For women with PCOS not seeking immediate pregnancy, initiate lifestyle modification targeting 5-10% weight loss as first-line therapy, followed by combined oral contraceptives for menstrual irregularity and hyperandrogenism symptoms, with metformin reserved for metabolic complications such as insulin resistance or impaired glucose tolerance. 1, 2
Diagnostic Workup
Essential Diagnostic Criteria
Use the Rotterdam criteria requiring two of three features: hyperandrogenism (clinical or biochemical), ovulatory dysfunction, and polycystic ovaries on ultrasound 3, 4. However, you must exclude other conditions before confirming PCOS.
Required Laboratory Testing
- Testosterone (total or free) or free androgen index to document hyperandrogenemia 2, 3
- 17-hydroxyprogesterone to exclude nonclassic congenital adrenal hyperplasia 3
- TSH to exclude thyroid disease 3
- Prolactin to exclude hyperprolactinemia 3
- Fasting lipid panel (total cholesterol, LDL, HDL, triglycerides) - all women with PCOS require dyslipidemia screening 5
- Fasting glucose and/or oral glucose tolerance test for metabolic screening 3
Physical Examination Priorities
Document terminal hair growth patterns, acne distribution, androgenic alopecia, acanthosis nigricans, and skin tags 3. Calculate BMI and measure waist circumference to assess metabolic risk 3.
Critical pitfall: Anti-Müllerian hormone should NOT be used for diagnosis 2, 3.
Management Algorithm for Non-Pregnancy Seeking Patients
First-Line: Lifestyle Modification (All Patients)
Target 5-10% weight loss through multicomponent intervention combining calorie-restricted diet (500-700 kcal/day deficit), exercise, and behavioral strategies 1, 2. Even 5% weight loss improves metabolic and reproductive abnormalities 5.
Exercise prescription: 150 minutes per week of moderate-to-high intensity aerobic exercise 2. Exercise provides benefits even without weight loss 5.
The evidence shows no specific diet type is superior, though low glycemic index foods are reasonable 2. Avoid high-protein diets due to concerns about renal function and lipid effects 5.
Second-Line: Pharmacologic Management Based on Primary Concern
For Menstrual Irregularity
Combined oral contraceptives are first-line pharmacologic therapy 5, 2. They suppress ovarian androgen secretion, increase sex hormone-binding globulin, and reduce endometrial cancer risk 5. Use the same screening criteria for contraindications as in the general population 2.
Alternative if contraceptives contraindicated: Cyclic progestins (medroxyprogesterone acetate) to induce withdrawal bleeds in amenorrheic women 5, 2. However, the optimal progestin type, duration, and frequency remain unclear 5.
For Hirsutism and Acne
First-line: Combined oral contraceptives 2, 5
Second-line: Add antiandrogen therapy (spironolactone, finasteride, or flutamide) to oral contraceptives for more severe cases 5. The combination of antiandrogen plus ovarian suppression is most effective, though no specific agent is proven superior 5.
FDA-approved topical option: Eflornithine hydrochloride cream is the only FDA-labeled treatment specifically for hirsutism 5, though additional benefits or risks in PCOS are unknown.
Adjunctive mechanical treatments: Photoepilation, laser vaporization, electrolysis, or cosmetic hair removal (plucking, shaving, waxing) 2, 5. Concomitant medical management is usually necessary as these are palliative rather than curative 5.
For Metabolic Complications
Metformin is first-line for metabolic manifestations including insulin resistance, impaired glucose tolerance, or type 2 diabetes risk 5. In women with PCOS using metformin, glucose tolerance improves or remains steady over time 5.
Important caveat: While metformin and thiazolidinediones may positively impact cardiovascular and diabetes risk factors, their role in primary or secondary prevention of cardiovascular disease remains unknown 5. The FDA has not labeled any insulin-sensitizing agent specifically for PCOS treatment 5.
Consider bariatric surgery for severely obese women if lifestyle modification fails to achieve sufficient weight loss 2.
Essential Screening and Monitoring
Metabolic Screening
- Screen for type 2 diabetes given four-fold increased risk compared to general population 4
- Screen for metabolic syndrome (twice as common in PCOS) 4
- Monitor lipids regularly given increased cardiovascular risk 5
Psychological Screening
Screen for depression and anxiety by history, with appropriate referral if identified 3. Mental health disorders occur more frequently in women with PCOS 6.
Sleep Disorders
Screen overweight/obese women for obstructive sleep apnea symptoms, obtaining polysomnography for definitive diagnosis when indicated 3.
Endometrial Protection
Women with PCOS have increased endometrial cancer risk due to chronic anovulation, obesity, hyperinsulinism, and diabetes 3. However, routine ultrasound screening for endometrial thickness is NOT recommended 3. Instead, ensure regular withdrawal bleeds through oral contraceptives or cyclic progestins.
Key Clinical Pearls
Weight stigma awareness: While addressing weight-related health risks is important, minimize weight stigma in all discussions 1.
No increased cardiovascular events with oral contraceptives: Despite increases in triglycerides and HDL cholesterol with oral contraceptive use in PCOS, no evidence suggests more cardiovascular events occur compared to the general population 5.
Avoid insulin-sensitizing agents as primary ovulation induction: While metformin and thiazolidinediones improve ovulation frequency, they are not first-line for fertility treatment 5. Their effects on early pregnancy are not well established 5.